Literature DB >> 1127773

Changes in the serum alpha glycoprotein distribution in trauma patients.

C J van Oss, P M Bronson, J R Border.   

Abstract

Serum electropherograms of trauma patients, when stained for glycoproteins, show striking changes in the alpha glycoproteins of these patients which revert to normal if and when they recover. Thus monitoring of the glycoprotidograms of trauma patients (contrary to ordinary protidograms) is likely to afford important information on the course of these patients' recovery. Of two glycoproteins that have been more closely studied, one, alpha1A acid glycoprotein, is a phagocytosis inhibitor; it is increased in the sera of trauma patients. The other, alpha2HS glycoprotein, is a phagocytosis promotor (or opsonin); it is decreased in the sera of trauma patients. Both the increase of the first and the decrease of the second glycoprotein may thus contribute to the known increased proneness to bacterial infection among these patients.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1127773     DOI: 10.1097/00005373-197505000-00013

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  11 in total

Review 1.  Cystatin superfamily.

Authors:  Josiah Ochieng; Gautam Chaudhuri
Journal:  J Health Care Poor Underserved       Date:  2010-02

2.  Decreased levels of alpha 2 HS-glycoprotein in children with protein-energy-malnutrition.

Authors:  P O Abiodun; J C Ihongbe; F Dati
Journal:  Eur J Pediatr       Date:  1985-11       Impact factor: 3.183

3.  Serum concentration of human alpha 2 HS glycoprotein during the inflammatory process: evidence that alpha 2 HS glycoprotein is a negative acute-phase reactant.

Authors:  J P Lebreton; F Joisel; J P Raoult; B Lannuzel; J P Rogez; G Humbert
Journal:  J Clin Invest       Date:  1979-10       Impact factor: 14.808

4.  Fetuin (alpha2-HS-glycoprotein) opsonizes cationic macrophagedeactivating molecules.

Authors:  H Wang; M Zhang; M Bianchi; B Sherry; A Sama; K J Tracey
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

5.  Serum alpha 2-HS glycoprotein concentration in patients with hematological malignancies. A follow-up study.

Authors:  L Kalabay; K Cseh; S Benedek; S Fekete; T Masszi; K Herjeczki; T Pozsonyi; L Jakab; L Jakab
Journal:  Ann Hematol       Date:  1991-11       Impact factor: 3.673

6.  The genetic polymorphism of alpha 2-HS glycoprotein: study by ultrathin-layer isoelectric focusing and immunoblot.

Authors:  B Boutin; S H Feng; P Arnaud
Journal:  Am J Hum Genet       Date:  1985-11       Impact factor: 11.025

Review 7.  Free drug concentration monitoring in clinical practice. Rationale and current status.

Authors:  C K Svensson; M N Woodruff; J G Baxter; D Lalka
Journal:  Clin Pharmacokinet       Date:  1986 Nov-Dec       Impact factor: 6.447

8.  Changes in levels of serum glycoproteins in major depressive disorders.

Authors:  Mukesh Nandave; S K Ojha; Ranjit Kaur
Journal:  Indian J Clin Biochem       Date:  2005-07

9.  Prevention of liver reticuloendothelial systemic host defense failure after surgery by intravenous opsonic glycoprotein therapy.

Authors:  T M Saba
Journal:  Ann Surg       Date:  1978-08       Impact factor: 12.969

10.  Variations in the serum concentration and urine excretion of alpha 2HS-glycoprotein, a bone-related protein, in normal individuals and in patients with osteogenesis imperfecta.

Authors:  I R Dickson; M Bagga; C R Paterson
Journal:  Calcif Tissue Int       Date:  1983       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.